Genomic Potential Articles & Analysis: Older
9 news found
In the ever-evolving world of genomics, CD Genomics, a leading provider of cutting-edge genomic solutions, has emerged as a pioneer in the field of fungal whole-genome de novo sequencing. ...
SeqOne Genomics, provider of nextgeneration genomic analysis solutions for personalized medicine, announces the appointment of Hervé Pouzoullic as Chief Commercial Officer (CCO). ...
The study also demonstrated that a comprehensive genomic characterization of CTCs based on the Minimally Invasive Multiple Myeloma sequencing (MinimuMM-seq)** process enabled the detection of translocations and copy number abnormalities through whole-genome sequencing of highly pure CTCs. These analyses showed that the myeloma cells captured in the blood ...
CD Genomics provides metatranscriptome sequencing data analysis service using bioinformatics analysis platform, which can comprehensively analyze the dynamic changes of microbial flora. ...
The primary purpose of integrating 4D’s proprietary algorithms within the ClinPx platform is to potentially improve the throughput, reliability, and quality of consultations provided by physicians. ...
By sequencing more than 99 percent of the SARS-CoV-2 genome, the assay covers all potential serotypes. The new Ion AmpliSeq SARS-CoV-2 Insight Research Assay broadens and improves local, regional and national surveillance efforts to discover emerging SARS-CoV-2 variants through highly sensitive next-generation sequencing (NGS). ...
“Amanda joins at a critical inflection point for Deep Genomics. The evolution of our AI Workbench has allowed us to rapidly identify genetically defined targets and design compounds with high therapeutic potential,” said Brendan Frey, Ph.D., FRSC, Founder and Chief Executive Officer of Deep Genomics. ...
In 2014, the entire genome of Cannabis stavia L. was sequenced. This news received national attention with eye-catching headlines such as: “Marijuana Genome Sequenced for Health, Not Highs”. ...
SEATTLE (March 29, 2017) Newly published, peer-reviewed results of observational clinical research have demonstrated that ID Genomics’ “bacterial fingerprinting” technology has the potential to improve antibiotic prescribing, reducing prescription errors and the overuse of broad-spectrum antibiotics, which could ultimately improve patient ...